Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03417297 · ClinicalTrials.gov registry record · NA
A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy
A NA study of Partial Seizures With Secondary Generalization and Focal Epilepsy With Secondary Generalization, sponsored by University of North Carolina, Chapel Hill.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03417297 is a NA study of Partial Seizures With Secondary Generalization and Focal Epilepsy With Secondary Generalization that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03417297, a NA study of Partial Seizures With Secondary Generalization and Focal Epilepsy With Secondary Generalization, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the safety and feasibility of unilateral focused ultrasound thalamotomy in adults with focal onset epilepsy whose medicines are not working well. The ExAblate (ExAblate) transcranial system is the name of the device that will be used to create and send ultrasound waves through the scalp and skull precisely to a small structure located in the center of the brain. This structure is known as the "Anterior Nucleus", and is an important region in the brain that may cause seizures. Safety will be measured by recording and analyzing the frequency of side effects throughout participation. Feasibility will be measured by the ability to create a lesion in the anterior nucleus.
Conditions Studied
Interventions
- DEVICE High Intensity Focused Ultrasound
Study Locations (1)
North Carolina
- University of North Carolina-Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-04-24 |
| Est. Completion | 2028-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03417297
The ClinicalTrials.gov registry entry for NCT03417297 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Partial Seizures With Secondary Generalization appearing as the primary indexed condition, and to 1 intervention - of which High Intensity Focused Ultrasound is the first listed.
NCT03417297 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03417297 about?
NCT03417297 is a clinical study titled "A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy". The purpose of this study is to assess the safety and feasibility of unilateral focused ultrasound thalamotomy in adults with focal onset epilepsy whose medicines are not working well. The ExAblate (ExAblate) transcranial system is the name of the device that will be used to create and send ultrasou...
What is the current status of trial NCT03417297?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2018-04-24. Estimated completion is 2028-05.
What conditions does trial NCT03417297 study?
This clinical trial studies the following conditions: Partial Seizures With Secondary Generalization, Focal Epilepsy With Secondary Generalization.
What interventions are being tested in trial NCT03417297?
The interventions under investigation include: High Intensity Focused Ultrasound (DEVICE).
Who is sponsoring clinical trial NCT03417297?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03417297 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Partial Seizures With Secondary Generalization
All registered trials for this condition
Focal Epilepsy With Secondary Generalization
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.